Norethindrone Acetate

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

22 Suppliers, 12 USDMF, 4 CEP/COS, 2 JDMF, 3 EU WC, 6 NDC API, 12 Listed Suppliers

DEVELOPMENTS

24 Drug(s) in Development

24 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

DOSSIERs // Finished Dosage Forms

135 Dossiers, 118 FDA Orange Book, 9 Europe, 6 Canada, 2 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL-28 - 0.02MG;1MG, TABLET;ORAL-21 - 0.03MG;1.5MG, TABLET;ORAL-21 - 0.03MG;1.5MG, TABLET;ORAL-21 - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-21 - 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.02MG;1MG, INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 11.25MG/VIAL,N/A;N/A,5MG, INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 3.75MG/VIAL,N/A;N/A,5MG, CAPSULE;ORAL - 0.02MG;1MG, TABLET, CHEWABLE, TABLET;ORAL - 0.01MG,0.01MG,N/A;1MG,N/A,N/A, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.14MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.25MG/24HR, TABLET;ORAL - 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 1MG;0.5MG, TABLET;ORAL - 0.0025MG;0.5MG, TABLET;ORAL - 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.01MG,0.01MG;1MG,N/A

RELATED EXCIPIENT COMPANIES

Suppliers, 38 Kerry, 23 Roquette, 19 BASF, 15 Microlex e.U, 13 Seppic, 12 Sigachi Industries, 11 Corel Pharma Chem, 11 Gangwal Chemicals, 9 Gangwal Healthcare, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 Ideal Cures Pvt Ltd, 7 DFE Pharma, 6 Lonza Capsugel, 6 Nanjing Well Pharmaceutical, 5 Vasa Pharmachem, 5 SPI Pharma, 4 Ingredion Pharma Solutions, 4 Actylis, 4 Boai NKY Pharmaceuticals Ltd, 4 Prachin Chemical, 3 Kima Chemical, 3 Pharmatrans-Sanaq, 2 Clariant, 2 Ulanqab Kema New Material, 2 Jai Radhe Sales, 2 Rochem International Inc, 2 The Dow Chemical Company, 2 DKSH, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Alcedo Pharmachem, 1 Huzhou Sunflower Pharmaceutical Co. Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 ACG Worldwide, 1 Pfanstiehl, 1 Nanjing Bold Chemical, 1 Qualicaps, 1 Doshion Polyscience, 1 Aeon Procare

EXCIPIENTS BY APPLICATIONS

77 Fillers, Diluents & Binders, 54 Coating Systems & Additives, 36 Direct Compression, 34 Disintegrants & Superdisintegrants, 29 Controlled & Modified Release, 26 Granulation, 25 Solubilizers, 20 Thickeners and Stabilizers, 20 Lubricants & Glidants, 18 Taste Masking, 15 Film Formers & Plasticizers, 14 Co-Processed Excipients, 13 Parenteral, 9 Emulsifying Agents, 8 Topical, 8 API Stability Enhancers, 7 Chewable & Orodispersible Aids, 6 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions, 10 Finished Drug Prices

MARKET PLACE

7 APIs

7 APIs

PATENTS

8 US Patents, 4 US Exclusivities

ANALYTICAL SOLUTION(s)

2 EDQM Standards, 1 USP Standards, 3 Other Ref. Standards

DIGITAL CONTENT

2 Data Compilation & Company Tracker #PharmaFlow, 47 News

Information, Expiry & Status of FDA Orange Book Patents covering Norethindrone Acetate

Norethindrone Acetate

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

22 Suppliers

12 USDMF

4 CEP/COS

2 JDMF

3 EU WC

6 NDC API

12 Listed Suppliers

DEVELOPMENTS

24 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

DOSSIERs // Finished Dosage Forms

135 Dossiers

118 FDA Orange Book

9 Europe

6 Canada

2 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL-28 - 0.02MG;1MG

TABLET;ORAL-21 - 0.03MG;1.5MG

TABLET;ORAL-21 - 0.03MG;1.5MG

TABLET;ORAL-21 - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-21 - 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.02MG;1MG

INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 11.25MG/VIAL,N/A;N/A,5MG

INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 3.75MG/VIAL,N/A;N/A,5MG

CAPSULE;ORAL - 0.02MG;1MG

TABLET, CHEWABLE, TABLET;ORAL - 0.01MG,0.01MG,N/A;1MG,N/A,N/A

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.14MG/24HR

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.25MG/24HR

TABLET;ORAL - 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 1MG;0.5MG

TABLET;ORAL - 0.0025MG;0.5MG

TABLET;ORAL - 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.01MG,0.01MG;1MG,N/A

RELATED EXCIPIENT COMPANIES

Suppliers

38 Kerry

23 Roquette

19 BASF

15 Microlex e.U

13 Seppic

12 Sigachi Industries

11 Corel Pharma Chem

11 Gangwal Chemicals

9 Gangwal Healthcare

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

7 Ideal Cures Pvt Ltd

7 DFE Pharma

6 Lonza Capsugel

6 Nanjing Well Pharmaceutical

5 Vasa Pharmachem

5 SPI Pharma

4 Ingredion Pharma Solutions

4 Actylis

4 Boai NKY Pharmaceuticals Ltd

4 Prachin Chemical

3 Kima Chemical

3 Pharmatrans-Sanaq

2 Clariant

2 Ulanqab Kema New Material

2 Jai Radhe Sales

2 Rochem International Inc

2 The Dow Chemical Company

2 DKSH

1 Qianhao Chemical (Hebei) Co., Ltd

1 Alcedo Pharmachem

1 Huzhou Sunflower Pharmaceutical Co. Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 ACG Worldwide

TABLET;ORAL-21 - 0.02MG;1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL-21 - 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.5MG;0.1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.005MG;1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.02MG;1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons